packageOlmutinib

olmutinib

Extends from Pharmacolibrary.Interfaces.PartialSubstance (Identity and physicochemical constants of one drug (Drugs.Substances)).

Information

Olmutinib is an investigational EGFR tyrosine kinase inhibitor studied as an anticancer drug, mainly for EGFR-mutated non-small cell lung cancer. It remains investigational and is not an approved medicine.

Summary written by glm-5.3-flash from Wikidata Q27088175 and the WHO ATC classification; not checked by a person.

name:olmutinib
ATC codes:L01EB06
DrugBank:DB13164
PubChem CID:54758501
Wikidata:Q27088175
formula:C26H26N6O2S
molar mass:486.594 g/mol (PubChem CID 54758501)
logP:4.7 (Drugs.Common 25.09, not verified)

Parameters

TypeNameDefaultDescription
Stringname (from PartialSubstance)""INN / common name
String[:]atcCodes (from PartialSubstance)fill("", 0)all WHO ATC codes of the drug
StringdrugbankId (from PartialSubstance)""e.g. DB00758
StringpubchemCid (from PartialSubstance)""PubChem compound id
StringchebiId (from PartialSubstance)""ChEBI id (number)
StringwikidataId (from PartialSubstance)""e.g. Q410238
Stringformula (from PartialSubstance)""molecular formula
Modelica.Units.SI.MolarMassM (from PartialSubstance)0molar mass; 0 = unknown
ReallogP (from PartialSubstance)Modelica.Constants.infoctanol-water partition coefficient (log10); inf = unknown